Royalty Pharma (RPRX) PT Raised to $64 at Morgan Stanley
Morgan Stanley analyst Terence Flynn ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)